Euglena Co., Ltd. (FRA:8EG)

Germany flag Germany · Delayed Price · Currency is EUR
1.710
0.00 (0.00%)
At close: Jun 26, 2026
Market Cap242.11M -32.6%
Revenue (ttm)281.63M +8.2%
Net Income-1.80M
EPS-0.01
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividend0.01 (0.63%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Open1.710
Previous Close1.710
Day's Range1.710 - 1.710
52-Week Range1.710 - 2.920
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 793
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8EG

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Financial numbers in JPY Financial Statements